Although topical [beta]-blockers are generally tolerated, they can produce significant
systemic side effects. The systemic side effects of nonselective [beta]-blockers (eg, timolol …

Rationale, aims, and objectives Despite recommendations in prevailing guidelines to avoid
the use of non‐selective (NS) β‐blockers in patients with asthma or COPD, on average, 10 …

At the time of their introduction, nearly 10 years ago, ophthalmic beta blockers offered an
alternative to other topical agents such as pilocarpine or epinephrine in the treatment of …

Purpose: To evaluate the yearly cost in 1998 of glaucoma medications to patients and to the
Health Plan at a university-affiliated teaching hospital with its own health maintenance …

The goals of glaucoma therapy for the patient and the physician are ultimately the same
ones, but they are often approached from very different perspectives. Most patients with …

PURPOSE: To determine rates of glaucoma medication utilization among glaucoma
suspects in the Medicare Current Beneficiary Survey (MCBS) and identify recent utilization …

Purpose. To compare the prevalence of side effects between eyedrops with or without
preservatives, in terms of subjective symptoms and objective signs in patients with open …

Objective: Recent advances in pharmacotherapy that have improved the ability to effect
sustained reductions in intraocular pressure may delay or obviate the need for surgery for …

Glaucoma, a group of eye diseases that share a characteristic pattern of deterioration of the
optic nerve, is a leading cause of blindness internationally. The treatment options for this …

Purpose To investigate persistence with glaucoma medication use and factors associated
with it among newly diagnosed Japanese patients. Patients and methods The subjects of …